Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05689502 · ClinicalTrials.gov registry record · NA

intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER)

A NA study of Chronic Stroke, sponsored by The University of Texas Health Science Center, Houston.

Active
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT05689502: Active NA study of Chronic Stroke, sponsored by The University of Texas Health Science Center, Houston.

NCT05689502 is a NA study of Chronic Stroke that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 9 participants, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05689502, a NA study of Chronic Stroke, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to Investigate the feasibility of a high-quality, high-dose, high-intensity upper extremity therapy program and to assess the treatment effects of a high-quality, high-dose, high-intensity upper extremity therapy program on functional outcomes, motor impairment, and quality of life

Conditions Studied

Interventions

  • DEVICE Treatment

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2023-03-20
Est. Completion 2026-12-31
Phase NA

What the registry record for NCT05689502 still lists

NCT05689502 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Treatment is the first listed.

NCT05689502 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05689502 about?

NCT05689502 is a clinical study titled "intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER)". The purpose of this study is to Investigate the feasibility of a high-quality, high-dose, high-intensity upper extremity therapy program and to assess the treatment effects of a high-quality, high-dose, high-intensity upper extremity therapy program on functional outcomes, motor impairment, and qual...

What is the current status of trial NCT05689502?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 9 participants. The study started on 2023-03-20. Estimated completion is 2026-12-31.

What conditions does trial NCT05689502 study?

This clinical trial studies the following conditions: Chronic Stroke.

What interventions are being tested in trial NCT05689502?

The interventions under investigation include: Treatment (DEVICE).

Who is sponsoring clinical trial NCT05689502?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05689502 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05689502's enrollment target sits among peer trials

9 18th of 20 higher than 3 of 20 other Chronic Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05689502, the US trial registry maintained by the National Library of Medicine. NCT05689502 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.